Pharmaceutical UK endocrine diseases specialist Diurnal Group has extended its exclusive license agreement with the specialty pharma company, Citrine Medicine, to include the registration, distribution and marketing of Efmody (hydrocortisone modified-release hard capsules – previously named Chronocort) covering China, Hong Kong, Taiwan and Macau. 12 May 2021